Cibus (CBUS) Gross Margin (2016 - 2023)
Cibus (CBUS) posted Gross Margin of 100.0% for Q1 2023, little changed sequentially from 100.0% in Q4 2022, and little changed YoY from 100.0% in Q1 2022.
Cibus (CBUS) Gross Margin (2016 - 2023) Analysis & Trends
Cibus has reported Gross Margin for 8 years, with the latest figure at 100.0% in Q1 2023.
- Quarterly Gross Margin changed 0.0% year-over-year to 100.0% in Q1 2023, while the trailing twelve-month figure through Mar 2023 was 100.0% (up 10090.0% YoY) and the FY2022 annual result came in at 100.0%, up 10989.0% from the prior year.
- Gross Margin was little changed at 100.0% in Q1 2023 per CBUS's latest filing, from 100.0% in the prior quarter.
- Over five years, Gross Margin peaked at 100.0% in Q1 2022 and troughed at 130.65% in Q2 2020.
- A 5-year average of 12.77% and a median of 3.14% in 2021 frame the typical range for Gross Margin.
- The sharpest annual moves came in 2020 and 2022: Gross Margin sank 15638 bps in 2020, then jumped 15323 bps in 2022.
- Over 5 years, Gross Margin stood at 43.86% in 2019, then grew by 19 bps to 35.44% in 2020, then surged by 91 bps to 3.14% in 2021, then soared by 3285 bps to 100.0% in 2022, then changed by 0 bps to 100.0% in 2023.
- According to Business Quant data, Gross Margin over the past three periods registered 100.0%, 100.0%, and 100.0% for Q1 2023, Q4 2022, and Q3 2022 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 85.33% |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 91.59% |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 90.43% |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 35.86% |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 89.76% |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 76.90% |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 84.20% |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 63.27% |
| 10 | Cibus | 131.25 Mn | 110.82 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 100.00% |
| Dec 31, 2022 | 100.00% |
| Sep 30, 2022 | 100.00% |
| Jun 30, 2022 | 100.00% |
| Mar 31, 2022 | 100.00% |
| Dec 31, 2021 | -3.14% |
| Sep 30, 2021 | -6.69% |
| Jun 30, 2021 | 2.97% |
| Mar 31, 2021 | -53.23% |
| Dec 31, 2020 | -35.44% |
| Sep 30, 2020 | -34.71% |
| Jun 30, 2020 | -130.65% |
| Mar 31, 2020 | -63.40% |
| Dec 31, 2019 | -43.86% |
| Sep 30, 2019 | -18.91% |
| Jun 30, 2019 | 25.74% |
| Mar 31, 2019 | 78.34% |
| Dec 31, 2018 | 100.00% |
| Sep 30, 2018 | 100.00% |
| Jun 30, 2018 | 100.00% |